Inflix Pharma Private Limited

Inflix Pharma Private Limited - pharma in Noida, Uttar Pradesh, India. Directors, charges & compliance details.
CIN U24239UP2021PTC154527 Incorporated 25 October 2021 ROC Kanpur HQ Noida, Uttar Pradesh, India
Active Private Limited Company pharma DPIIT Startup MSME · Micro
Revenue · FY 2025
₹16.97 Lakh
▼ 39% YoY
Net profit · FY 2025
₹10,494
Net margin 0.6%
EBITDA · FY 2025
₹20,000
EBITDA margin 1.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Inflix Pharma Private Limited

Data last updated:

Inflix Pharma Private Limited is a private limited company based in Noida, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 October 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24239UP2021PTC154527. Its GSTIN is 09AAGCI3770A1ZR (Uttar Pradesh).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Saira Bano and Manoj Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No.40 Panchkula 3rd Colony Chhapraula Dadri, Noida, Uttar Pradesh, India – 201001.

As per the financials filed for FY 2025, the company reported a revenue of ₹16.97 Lakh, a decline of 39% compared to the previous year. For the same year it recorded a net profit of ₹10,494 (net margin 0.6%) and EBITDA of ₹20,000 (EBITDA margin 1.2%).

Inflix Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0034366).

Company details

CIN U24239UP2021PTC154527
Registration Number 154527
Incorporation Date 25 October 2021
ROC Kanpur
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-UP-28-0034366

Recognitions & Rankings of Inflix Pharma

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-UP-28-0034366

Contact details

Inflix Pharma Private Limited's registered office is in Noida, Uttar Pradesh.

  • Registered Address
    House No.40 Panchkula 3rd Colony Chhapraula Dadri, Noida, Uttar Pradesh, India – 201001
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Inflix Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Inflix Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Inflix Pharma Private Limited, buy the company report.

Financials of Inflix Pharma Private Limited

FY 2025 filings available

Inflix Pharma Private Limited reported revenue of ₹16.97 Lakh (down 39% YoY) for FY 2025.

Revenue · FY 2025
₹16.97 Lakh ▼ 39%
Net profit · FY 2025
₹10,494 margin 0.6%
EBITDA · FY 2025
₹20,000 margin 1.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 39%
EBITDA CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 595%

Revenue fell 39% in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹20,000
Profit Before Tax
Tax Expense
Net Profit (PAT)₹10,494
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin1.2%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Inflix Pharma Private Limited, buy the company report.

Board of directors of Inflix Pharma Private Limited

Inflix Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Saira BanoDirector25 Oct 20215 Years 0 MonthsCurrent
Manoj KumarDirector25 Oct 20215 Years 0 MonthsCurrent

Peer comparison

Inflix Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Tradetree Global Private Limited₹16.98 Lakh (FY 2021)-68.0%Noida, Uttar Pradesh, India
Blackhawk Med Private Limited₹16.98 Lakh (FY 2023)579.0%Lucknow, Uttar Pradesh, India
Unisars Health Care Private Limited₹16.98 Lakh (FY 2025)-87.0%Agra, Uttar Pradesh, India
Watech Chemicals Private Limited₹16.97 Lakh (FY 2024)5.0%Chennai, Tamil Nadu, India
Tiptop Traders Pvt Ltd₹16.97 Lakh (FY 2024)-8.0%Kolkata, West Bengal, India
Inflix Pharma Private Limitedthis company₹16.97 Lakh (FY 2025)₹10,4940.6%-39.0%Noida, Uttar Pradesh, India
Yoravis Trading Private Limited₹16.97 Lakh (FY 2022)Thane, Maharashtra, India
Shivmangal Vinimay Private Limited₹16.97 Lakh (FY 2024)-8.0%Kolkata, West Bengal, India
Medlandos Pharmaceuticals Private Limited₹16.97 Lakh (FY 2023)-63.0%Salem, Tamil Nadu, India
Balaji Bio Plantteec Tecnology Private Limited (OPC)₹16.97 Lakh (FY 2023)317.0%Samastipur, Bihar, India
S.P.G Fertilizers Private Limited₹16.96 Lakh (FY 2025)-78.0%Hooghly, West Bengal, India

To see the full peer comparison of Inflix Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Inflix Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Inflix Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAGCI3770A1ZRUttar PradeshActive10 Feb 2022

To see the full GST registrations and return filing status of Inflix Pharma Private Limited, buy the company report.

Recent activity

Inflix Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Manoj Kumar was appointed as Director on 25 Oct 2021.

AGM
Inflix Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Inflix Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Appointed
Manoj Kumar was appointed as Director.
Appointed
Saira Bano was appointed as Director.
Incorporation
25 Oct 2021
Inflix Pharma Private Limited was registered on 25 Oct 2021 with Roc Kanpur & aged 5 years 25 days as per MCA records.

Frequently asked questions

Inflix Pharma is an active private limited company based in Noida, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 October 2021 (5+ years old) and is registered under CIN U24239UP2021PTC154527.

Inflix Pharma has 2 current directors:

The latest financial statements of Inflix Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Inflix Pharma is 09AAGCI3770A1ZR, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Inflix Pharma is U24239UP2021PTC154527. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Inflix Pharma was incorporated on 25 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kanpur.

The peers of Inflix Pharma by revenue are Tradetree Global Private Limited, Blackhawk Med Private Limited, Unisars Health Care Private Limited, Watech Chemicals Private Limited, Tiptop Traders Pvt Ltd and 5 more, all in the same principal business activity (wholesale trading).

Manoj Kumar was appointed as Director on 25 Oct 2021. Saira Bano was appointed as Director on 25 Oct 2021.

Yes, Inflix Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Inflix Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0034366).

The registered office of Inflix Pharma is at House No.40 Panchkula 3rd Colony Chhapraula Dadri, Noida, Uttar Pradesh, India – 201001.